AUS
NZ
UK
CA
USA
IND
Highlights:
The ASX 200 index lifted by the end of the trading day after a subdued start, marking a continuation of recent gains across the Australian market. The rebound was supported by strong performance in the technology and financial sectors, with investors shifting sentiment midway through the session. The local bourse remains below its annual average but has gained traction over the past week.
Tech stocks were key contributors to the index’s upward movement, while discretionary and banking names also offered support, reinforcing a balanced rally across sectors.
Xero (ASX:XRO) Delivers Strong Earnings
Xero (ASX:XRO), a prominent cloud-based accounting software company, recorded a significant rise in both profit and revenue in its latest report. Although it missed its net profit after tax benchmark, the company reported robust growth across core earnings metrics. This performance lifted XRO shares, placing it among the top movers on the ASX 200.
The stock’s momentum reflects confidence in its consistent customer base among businesses and resilience in delivering financial outcomes even amid broader economic pressures.
Insurance Australia Group (ASX:IAG) Surges on Strategic Alliance
Insurance Australia Group (ASX:IAG) was among the strongest performers after finalizing a deal with the Royal Automobile Club of Western Australia. The agreement includes the acquisition of RAC Insurance and a long-term exclusive partnership to distribute RAC-branded insurance products.
This move grants IAG access to a large member base and strengthens its position in the Western Australian insurance market, contributing to its outperformance within the insurance sub-index.
Major Banks Climb on Broader Optimism
Key banking institutions including Commonwealth Bank (ASX:CBA), Westpac (ASX:WBC), National Australia Bank (ASX:NAB), ANZ Group (ASX:ANZ), and Macquarie Group (ASX:MGQ) closed higher. Gains across these institutions bolstered the broader ASX 200 Banks index, reflecting optimism in financial services and stability in lending markets.
Peak Rare Earths (ASX:PEK) Leads Small Cap Rally
Peak Rare Earths (ASX:PEK) staged a dramatic surge after announcing a takeover by Chinese firm Shenghe via its Chenguang subsidiary. The offer includes a significant premium on the previous close, pushing PEK shares sharply higher as the deal advances through approval stages.
Biotechs Show Progress with Trial Milestones
Amplia Therapeutics (ASX:ATX) advanced after confirming multiple positive responses in its pancreatic cancer trial. The drug narmafotinib, combined with standard chemotherapy, demonstrated enhanced efficacy, with top-line data expected soon.
Chimeric Therapeutics (ASX:CHM) also posted gains after its ADVENT-AML trial achieved full remission in a majority of initial patients treated for Acute Myeloid Leukemia. Importantly, no safety concerns were observed, suggesting a promising profile for early-stage treatment options.
Small Cap Movers and Trading Halts
Several small-cap stocks posted double-digit gains, including 8Common (ASX:8CO), EDU Holdings (ASX:EDU), and Latrobe Magnesium (ASX:LMG). On the downside, Lanthanein Resources (ASX:LNR), ECS Botanics (ASX:ECS), and Vital Metals (ASX:VML) recorded notable losses.
A series of trading halts were in place for companies announcing capital raisings, acquisitions, and clinical updates, such as Alvo Minerals (ASX:ALV), Chimeric Therapeutics (ASX:CHM), and GreenX Metals (ASX:GRX).
Exploration and Resource Updates
Anson Resources (ASX:ASN) is set to re-enter its lithium brine project in Utah, aiming to expand its resource base. Meanwhile, E79 Gold Mines (ASX:E79) will commence drilling at its Laverton South project, building on new target zones identified from data reviews.
Blue Star Helium (ASX:BNL) and MTM Critical Metals (ASX:MTM) also shared updates, the former highlighting improved helium flow rates and the latter securing leasing terms for a metal recovery facility in the US.
